Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications.

Islam S, Dasgupta H, Basu M, Roy A, Alam N, Roychoudhury S, Panda CK

DOI: 10.1007/s13402-020-00525-5
Published: 2020 Aug
Container: Cellular oncology (Dordrecht, Netherlands)
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13402-020-00525-5,
  title = {Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications.},
  author = {Islam S and Dasgupta H and Basu M and Roy A and Alam N and Roychoudhury S and Panda CK},
  year = {2020},
  journal = {Cellular oncology (Dordrecht, Netherlands)},
  doi = {10.1007/s13402-020-00525-5},
  url = {https://doi.org/10.1007/s13402-020-00525-5}
}

RIS

TY  - JOUR
TI  - Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications.
AU  - Islam S
AU  - Dasgupta H
AU  - Basu M
AU  - Roy A
AU  - Alam N
AU  - Roychoudhury S
AU  - Panda CK
PY  - 2020
JO  - Cellular oncology (Dordrecht, Netherlands)
DO  - 10.1007/s13402-020-00525-5
UR  - https://doi.org/10.1007/s13402-020-00525-5
ER  -

APA

S, I., H, D., M, B., A, R., N, A., S, R., & CK, P. (2020). Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications.. Cellular oncology (Dordrecht, Netherlands). https://doi.org/10.1007/s13402-020-00525-5

Source records

pubmed · retrieved 2026-09-24T22:43:03.675Z